Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Health Secretary Vaughan Gething announces all-Wales PrEP trial

The Health Secretary Vaughan Gething has announced an all-Wales study to provide the drug Truvada® to all those who would benefit from the preventative treatment.

Published
28 April 2017
From
Welsh Government
Nelly Mugo—rolling out PrEP in Kenya

Nelly Mugo has had a central role in building evidence for PrEP, as a co-author on the Partners PrEP study. Most of her current work is focused on scale-up and roll-out of PrEP.

Published
28 April 2017
From
The Lancet (free registration required)
‘Postcode lottery’ for HIV-preventing drugs as England, Scotland and Wales split on issue

England, Scotland and Wales will end up with divergent rules on the use of HIV-preventing drugs, after a recommendation against providing the drugs on the NHS from the Welsh medicines advisory body.

Published
28 April 2017
From
Pink News
Are women prepared for HIV PrEP?

Did you know that you can take a drug to reduce your risk of getting HIV? If you're a gay man, you've probably heard of it. But PrEP doesn’t only benefit men, and some women and trans folks are wondering why a drug that could potentially save their lives hasn’t been aggressively promoted in their communities.

Published
28 April 2017
From
KALW
British HIV Association (BHIVA) statement on Wales' failure to approve Pre-Exposure Prophylaxis (PrEP) for HIV prevention

Although a final decision is yet to be announced, the All Wales Medicines Strategy Group (AWMSG) has indicated that Wales will not join Scotland in recommending the provision of Pre-Exposure Prophylaxis (PrEP) by the NHS for the prevention of HIV. BHIVA Chair, Professor Chloe Orkin, said: "A negative decision would be a harsh blow for those of us throughout the UK at the front line of HIV prevention and care."

Published
26 April 2017
From
BHIVA
PrEP 17 – The coming of age of PrEP - coming soon

This 36 minute documentary film, commissioned by PrEPster, shines a light on how PrEP has become available to thousands of people in Britain, despite the failures of the English health system.

Published
26 April 2017
From
PrEPster
Prescribers of PrEP don't see most patients increasing risky sexual behavior

A new study examining medical provider attitudes toward prescribing PrEP to prevent HIV found that those who already prescribe it do not see widespread increases in risky sexual behavior among their patients as a result.

Published
26 April 2017
From
Eurekalert Medicine & Health
Thai HIV Advocates Drop the PrEP Ball

It is astonishing that strong, albeit subtle, resistance for PrEP scale-up in Thailand comes from a few influential leaders of HIV NGOs. Small in number, these NGOs are vocal and influential. Their opinions are esteemed by government officials and fellow NGOs. The resistance is not stated in public. Most of the objections to PrEP I have heard from these individuals during backroom talks or various office meetings or private discussions. Concerns, doubts, or cautions against PrEP that are said in public were vague and ambivalent.

Published
25 April 2017
From
AVAC
BHIVA response to The Irish Times article 'Anti-HIV drug removes personal responsibility'

This piece has generated a considerable amount of concern in the HIV community already as its content is completely at odds with current recommendations by the World Health Organisation and NICE which recognise that HIV pre-exposure prophylaxis (PrEP) is an important component of HIV prevention. Numerous studies have shown that PrEP is a highly clinically and cost-effective safe intervention which reduces the risk of becoming infected with HIV by around 90%.

Published
24 April 2017
From
BHIVA
Anti-HIV drug removes personal responsibility

I would argue that Pre-exposure Prophylaxis is a solution which removes personal responsibility in relation to the transmission of HIV, increases the practice of unprotected sexual behaviour and will, ultimately, be responsible for widespread liver disease among gay populations in 10-15 years from now.

Published
20 April 2017
From
Irish Times
← First12345...110Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.